Lv3
208 积分 2023-04-18 加入
Looking through the window of opportunity in axial spondyloarthritis?
1天前
待确认
Treatment of recalcitrant psoriasis and psoriatic arthritis with a combination of a biologic plus an oral JAK or TYK2 inhibitor: a case series
3天前
已完结
Long-term effectiveness and safety of deucravacitinib in psoriasis: A 52-week real-world study of genital, scalp, and nail lesions
8天前
已完结
Adherence to Psoriasis Therapies
21天前
已完结
Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation
22天前
已完结
Biologic Vs Conventional Therapies: Comparing Risk of Psoriasis-Associated Comorbidities
23天前
已完结
The burden of skin diseases in China: global burden of Disease Study 2019
24天前
已完结
Deucravacitinib: The First FDA-Approved Oral TYK2 Inhibitor for Moderate to Severe Plaque Psoriasis
29天前
已完结
A Review of the Safety and Efficacy of Deucravacitinib for Plaque Psoriasis: An Expert Consensus Panel
29天前
已完结
Acute glomerulonephritis
1个月前
已完结
Advances in research on malignant tumors and targeted agents for TOP2A (Review)
1个月前
已采纳
中国高血压患者教育指南
1个月前
已采纳
Insights from lymphoedema healthcare professionals managing lipalgia syndrome (lipoedema): a service evaluation
2个月前
已采纳
SINS/USBL组合定位技术研究
2个月前
已采纳
Empowerment and silence: A grounded theory exploration among new teachers
3个月前
已采纳
皖公网安备34019202002308
